Reference health

The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial

https://doi.org/10.1186/1471-2458-12-1052
CiteStamped reference-health badge
18/18 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 18 checked references that resolve
resolves10.1111/j.1360-0443.2004.00540.x
Shape of the relapse curve and long‐term abstinence among untreated smokers
resolves10.1038/clpt.1988.107
Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum
resolves10.1111/j.1360-0443.1994.tb03738.x
Neural mechanisms underlying nicotine dependence
resolves10.1021/jm050069n
Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
resolves10.1001/jama.296.1.47
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
resolves10.1056/NEJMoa1102035
Placebo-Controlled Trial of Cytisine for Smoking Cessation
resolves10.4161/hv.5.4.7310
Vaccines against nicotine
resolves10.1159/000063617
A Vaccine for Nicotine Dependence: Targeting the Drug Rather than the Brain
resolves10.1021/jo001442w
An Immunotherapeutic Program for the Treatment of Nicotine Addiction:  Hapten Design and Synthesis
resolves10.1038/clpt.2010.317
Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic
resolves10.2165/11599900-000000000-00000
Nicotine Vaccines to Assist with Smoking Cessation
resolves10.1016/j.clpt.2005.08.007
Safety and immunogenicity of a nicotine conjugate vaccine in current smokers
resolves10.1080/14622200701704921
The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1/2 trial
resolves10.1001/jama.296.1.56
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
resolves10.1111/j.1360-0443.2007.01946.x
Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation
resolves10.2165/00002018-200528010-00002
Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions
resolves10.1185/030079905X43712
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale
resolves10.1111/j.1360-0443.1991.tb01879.x
The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
The 7 references without a DOI — listed, not checked
no DOI — not checkedWorld Health Organization: WHO report on the global tobacco epidemic 2011, warning about the dangers of tobacco. 2011, http://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf ,
no DOI — not checkedCenters for disease control and prevention: Great American Smokeout, Quitting Smoking Among Adults - United States 2001 – 2010. 2010, http://www.cdc.gov/mmwr/pdf/wk/mm6044.pdf ,
no DOI — not checkedStead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008, 1: CD000146
no DOI — not checkedHughes J, Stead L, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004, 4: CD000031
no DOI — not checkedCahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012, 4: CD006103
no DOI — not checkedLancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2002, CD001292
no DOI — not checkedNabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial. http://phx.corporate-ir.net/phoenix.zhtml?c=100445&p=irol-newsArticle&ID=1626882&highlight= ,
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1186/1471-2458-12-1052"><img src="https://citestamp.com/citestamped/10.1186/1471-2458-12-1052/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1186/1471-2458-12-1052/badge.svg)](https://citestamp.com/citestamped/10.1186/1471-2458-12-1052)